The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024.

Revenue
+0.56%
EPS
+357.1%
Free cash flow
+66.0%
Total debt
+2.66%

Quarter to July 2026, against a year earlier

62.70 0.81 −1.28%
Market cap
$12.1B
P/E
21.7×
Fwd P/E
17.5×
Dividend yield
—
F-score
5/9
Altman Z
3.48
Beneish M
−2.50
Dividend safety
n/a

The Cooper Companies, Inc. (COO) SEC filings, changes and red flags

Red flags

  • Officer departure

    The Cooper Companies, Inc. reported the departure of its Chief Executive Officer

    8-K filed · The filing · sec.gov

  • Auditor’s opinion

    The Cooper Companies, Inc.’s auditor’s report on its 10-K is not a clean opinion, or points to a restatement

    We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of October 31, 2024, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated December 6, 2024 expressed an adverse opinion on the effectiveness of the Company's internal control over financial reporting.

    10-K filed · The filing · sec.gov

  • Material weakness

    The Cooper Companies, Inc.’s 10-Q reports a material weakness in internal control over financial reporting

    Based on management’s evaluation (with the participation of our Chief Executive Officer (our Principal Executive Officer) and Chief Financial Officer (our Principal Financial Officer)), as of the end of the period covered by this report, due to the material weakness described below, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the Exchange Act)) are not effective as of April 30, 2025 to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

    10-Q filed · The filing · sec.gov

Filings

Form Period Filed What it reports Flags
8-K Oct 27, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits Officer departure
10-Q Jul 31, 2026 P1I2: 16 added · 4 removed · 24 modified
P2I1A: no material changes, the filing says
8-K Sep 9, 2026 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Apr 30, 2026 P1I2: 11 added · 3 removed · 30 modified
P2I1A: no material changes, the filing says
8-K Jun 4, 2026 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
8-K May 4, 2026 5.02 Departure or appointment of directors or officers
8-K Apr 7, 2026 5.07 Submission of matters to a vote of security holders
10-Q Jan 31, 2026
8-K Mar 5, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 3, 2026 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits
8-K Dec 22, 2025 1.01 Entry into a material definitive agreement; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Dec 9, 2025 5.02 Departure or appointment of directors or officers
10-K Oct 31, 2025 1: 15 added · 3 removed · 31 modified
1A: 3 added · 53 modified
7: 11 added · 8 removed · 30 modified
8-K Dec 4, 2025 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Jul 31, 2025 P1I2: 6 added · 3 removed · 18 modified
P2I1A: no material changes, the filing says
8-K Aug 27, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Apr 30, 2025 Material weakness
8-K May 29, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jan 31, 2025
8-K Mar 6, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Oct 31, 2024 Auditor’s opinion
8-K Dec 5, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jul 31, 2024
8-K Aug 28, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 30, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 29, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Dec 6, 2023 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.